Cardiol Therapeutics Inc.

NASDAQ:CRDL

1.83 (USD) • At close October 29, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q2
Revenue 0000000000000.0790000000000000000
Cost of Revenue 0.0620.0620.0670.0650.0580.0580.0580.0540.0540.0540.0560.05600.055000000000000000
Gross Profit -0.062-0.062-0.067-0.065-0.058-0.058-0.058-0.054-0.054-0.054-0.056-0.0560.079-0.055000000000000000
Gross Profit Ratio 00000000000010000000000000000
Reseach & Development Expenses 2.713.3234.042.5773.4794.1285.6185.0894.4073.8483.5282.5921.92.6097.2121.9010.8180.5841.0311.2380.7480.5130.2810.4470.5480.2560.1170.110.214
General & Administrative Expenses 5.0325.0833.9885.0792.8353.6583.4778.1314.8255.9419.577.5724.5486.3162.3482.4532.7082.4362.212.3072.9682.9632.9691.9660.6790.2560.4330.3810.111
Selling & Marketing Expenses -0.062-0.0623.91800000000000000000000000000.061
SG&A 4.975.0213.9225.0792.8353.6583.4778.1314.8255.9419.577.5724.5486.3162.3482.4532.7082.4362.212.3072.9682.9632.9691.9660.6790.2560.4330.3810.172
Other Expenses -00.02800.150000.164000.0190.093000000.0070.21900.0800-0.26800-0.018-0.0220
Operating Expenses 7.6798.3447.9627.6566.3157.7869.09513.229.2329.78813.09810.1646.5028.989.6194.4113.5843.0773.2913.5843.7543.4993.2742.4361.250.5350.5710.5070.43
Operating Income -7.741-8.405-8.029-7.656-4.629-7.937-10.09-17.915-11.784-10.551-19.891-10.288-6.26-9.034-9.599-4.387-3.57-3.05-3.031-3.523-3.607-3.423-3.214-2.396-1.248-0.533-0.565-0.507-0.401
Operating Income Ratio 000000000000-79.4840000000000000000
Total Other Income Expenses Net 1.15-0.7740.3921.21-1.6860.1510.9954.8592.5510.7626.8120.218-0.1630.054-0.067-0.014-0.0540.1090.1920.0310.044-0.068-5.591-2.247-0.002-0.019-0.005-0.006-0.042
Income Before Tax -6.591-9.18-7.637-5.93-7.472-7.089-7.515-7.972-6.489-8.954-6.257-9.91-6.561-8.91-9.667-4.401-3.625-2.949-3.059-3.492-3.643-3.491-9.074-4.91-1.358-0.552-0.588-0.536-0.443
Income Before Tax Ratio 000000000000-83.3030000000000000000
Income Tax Expense 0-0-0-1.5761.157-0.697-1.58-5.084-2.743-0.834-6.821-0.1610.138-0.070000.0070.21900.080.0010.2690.2680.10800.0180.0220
Net Income -6.591-9.18-7.637-5.93-7.472-7.089-7.515-7.972-6.489-8.954-6.257-9.91-6.561-8.91-9.667-4.401-3.625-2.949-3.059-3.492-3.643-3.491-9.074-4.91-1.358-0.552-0.588-0.536-0.443
Net Income Ratio 000000000000-83.3030000000000000000
EPS -0.096-0.14-0.12-0.092-0.12-0.11-0.12-0.13-0.1-0.14-0.11-0.23-0.16-0.26-0.29-0.13-0.13-0.11-0.12-0.13-0.14-0.14-0.4-0.22-0.06-0.024-0.026-0.024-0.034
EPS Diluted -0.096-0.14-0.12-0.092-0.12-0.11-0.12-0.13-0.1-0.14-0.11-0.23-0.16-0.26-0.29-0.13-0.13-0.11-0.12-0.13-0.14-0.14-0.4-0.22-0.06-0.024-0.026-0.024-0.034
EBITDA -7.679-8.344-7.962-8.651-4.57-7.879-10.032-17.86-11.73-10.497-19.835-10.233-6.206-8.979-9.541-4.33-3.513-2.993-2.981-3.483-3.57-3.399-3.19-2.373-1.225-0.51-0.543-0.491-0.393
EBITDA Ratio 000000000000-78.7910000000000000000